There were no differences in the LAM group regarding MMP-2 levels and LT: LAM patients had a median of 551 (462–783) ng/ml compared with one of 630 (491–901) ng/ml in LAM LT patients (p > 0.999). This evidence concerns the gene MMP2 and lymphangioleiomyomatosis.